To confirm the role of combination STAT3 downregulation and anti-PD-1 treatment on CD8+ T cells, we analyzed the cell phenotype and cytokine expression pattern of CD8+ T cells in melanoma (Figures S4A–C). Here, CD8A is linked to melanoma.